Structural Heart Devices Market Size, Share, Demand
Overview, Growth Values, Trends: Type (Heart Valve Devices, Annuloplasty Rings,
Occluders, and Delivery Systems), Indication (Valvular Heart Disease,
Cardiomyopathy), Procedure (Replacement Procedures, Repair Procedures)–Global
Forecast Till 2023
Market Overview:
Factors included in the market report are the hike in investment
for the research and development facilities, better inclusion of advanced
technologies, and rising demand for minimally-invasive surgeries. Various
private and public organizations are ensuring the maintenance of a proper line
of investment flow during the forecast period. A surge in demand for
minimally-invasive surgeries is providing scope for the incorporation of
advanced technologies. In developing regions, growing development in the
healthcare facilities is going to attract better investment and ensure a hike
in market revenues.
The global Structural
Heart Devices Market Growth Supposed to
score a CAGR of 10.4% during the forecast period of 2018 to 2023. Market Research
Future (MRFR), in its report, dealt with several factors and restraints to
understand the market flow.
However, the high cost of products can be a restraint for the
global structural heart devices market. In addition, stringent government
policies can deter growth.
Competitive Landscape:
Medtronic plc (Ireland), Edwards Lifesciences Corporation (US),
LivaNova plc (UK), Abbott (US), Boston Scientific Corporation (US), ST. Jude
Medical, Biomerics, Comed BV, JenaValve Technology, Inc., Endologix Inc. (US).,
Cook Group Incorporated (US), CardioKinetix, and W. L. Gore & Associates,
Inc. (US).
Segmentation:
·
MRFR analysts have segmented
the global structural heart devices market into type, indication, procedure,
and end-user to allow a better understanding of the market.
·
By type, the global market
study includes segments like occluders and delivery systems, annuloplasty
rings, accessories, heart valve devices, and other devices.
·
By indication, the market
study covers segments like cardiomyopathy, congenital heart defects, valvular
heart disease, and others.
·
By procedure, the market
report comprises segments like Replacement Procedures and repair procedures.
The segment of Replacement Procedures includes TAVR procedures and SAVR procedures.
·
By end-users, the market
report on the structural heart devices market includes ambulatory surgery
centers, hospitals, and others.
Regional Analysis:
North America would lead the global market for its easy
incorporation of structural heart medical devices in the medical sector. High
investment capacity can also boost the regional market growth. The Asia Pacific
region would gain from growing investment in the healthcare sector and market
expansion plans of the top plaayers who find the region as a profit-making
opportunity.
Industry News:
In March 2020, Keystone Heart Ltd., a part of the Venus Medtech
Company, declared that its TriGUARD 3 Cerebral Embolic Protection (CEP) Device
products received European CE Mark. The device can be used to minimalize the
impact of cerebral damage. The machine follows a path where it deflects the
embolic debris away from cerebral circulation while the Transcatheter Aortic
Valve Implantation (TAVI) and other transcatheter heart procedures are on. This
will boost the global structural heart devices market.
NOTE
: Our team of researchers are studying Covid19 and its impact on various
industry verticals and wherever required we will be considering covid19
footprints for a better analysis of markets and industries. Cordially get in
touch for more details.
Comments
Post a Comment